Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$102.07 - $123.37 $218,531 - $264,135
-2,141 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $46,178 - $56,311
-405 Reduced 15.91%
2,141 $253,000
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $36,507 - $44,701
-316 Reduced 11.04%
2,546 $358,000
Q3 2021

Oct 06, 2021

SELL
$116.66 - $129.06 $37,331 - $41,299
-320 Reduced 10.06%
2,862 $338,000
Q2 2021

Jul 06, 2021

SELL
$105.79 - $124.53 $2.04 Million - $2.4 Million
-19,286 Reduced 85.84%
3,182 $369,000
Q1 2021

Apr 07, 2021

BUY
$108.84 - $128.23 $757,199 - $892,096
6,957 Added 44.85%
22,468 $2.69 Million
Q4 2020

Feb 01, 2021

SELL
$105.0 - $114.42 $13,440 - $14,645
-128 Reduced 0.82%
15,511 $1.7 Million
Q3 2020

Oct 15, 2020

SELL
$91.64 - $111.29 $238,630 - $289,799
-2,604 Reduced 14.27%
15,639 $1.7 Million
Q2 2020

Jul 22, 2020

BUY
$76.57 - $98.0 $97,167 - $124,362
1,269 Added 7.48%
18,243 $1.67 Million
Q1 2020

May 04, 2020

SELL
$62.82 - $91.86 $173,194 - $253,258
-2,757 Reduced 13.97%
16,974 $1.34 Million
Q4 2019

Feb 04, 2020

BUY
$78.51 - $87.4 $109,128 - $121,486
1,390 Added 7.58%
19,731 $1.71 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $466,569 - $505,906
5,701 Added 45.1%
18,341 $1.54 Million
Q2 2019

Aug 22, 2019

BUY
$72.88 - $85.0 $72,952 - $85,085
1,001 Added 8.6%
12,640 $1.06 Million
Q1 2019

Apr 15, 2019

SELL
$66.22 - $80.06 $160,517 - $194,065
-2,424 Reduced 17.24%
11,639 $930,000
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $5,703 - $6,461
87 Added 0.62%
14,063 $1.02 Million
Q3 2018

Oct 29, 2018

SELL
$60.81 - $73.36 $6,081 - $7,336
-100 Reduced 0.71%
13,976 $1.03 Million
Q2 2018

Jul 26, 2018

BUY
$57.57 - $63.54 $2,648 - $2,922
46 Added 0.33%
14,076 $858,000
Q1 2018

May 03, 2018

BUY
$56.27 - $63.62 $87,893 - $99,374
1,562 Added 12.53%
14,030 $841,000
Q4 2017

Feb 06, 2018

BUY
$53.68 - $57.47 $669,282 - $716,535
12,468
12,468 $712,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hodges Capital Management Inc. Portfolio

Follow Hodges Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hodges Capital Management Inc. with notifications on news.